Orozco O - Search Results

1

Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor.

Gerard C, Bao L, Orozco O, Pearson M, Kunz D, Gerard NP. Gerard C, et al. Among authors: orozco o. J Immunol. 1992 Oct 15;149(8):2600-6. J Immunol. 1992. PMID: 1401897

2

Expression of Radical fringe in limb-bud ectoderm regulates apical ectodermal ridge formation.

Laufer E, Dahn R, Orozco OE, Yeo CY, Pisenti J, Henrique D, Abbott UK, Fallon JF, Tabin C. Laufer E, et al. Among authors: orozco oe. Nature. 1997 Mar 27;386(6623):366-73. doi: 10.1038/386366a0. Nature. 1997. PMID: 9121552

3

GFRalpha3 is expressed predominantly in nociceptive sensory neurons.

Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M. Orozco OE, et al. Eur J Neurosci. 2001 Jun;13(11):2177-82. doi: 10.1046/j.0953-816x.2001.01596.x. Eur J Neurosci. 2001. PMID: 11422460

4

BMP expression in duck interdigital webbing: a reanalysis.

Laufer E, Pizette S, Zou H, Orozco OE, Niswander L. Laufer E, et al. Among authors: orozco oe. Science. 1997 Oct 10;278(5336):305. doi: 10.1126/science.278.5336.305. Science. 1997. PMID: 9340773 No abstract available.

5

Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus artemin.

Carmillo P, Dagø L, Day ES, Worley DS, Rossomando A, Walus L, Orozco O, Buckley C, Miller S, Tse A, Cate RL, Rosenblad C, Sah DW, Grønborg M, Whitty A. Carmillo P, et al. Among authors: orozco o. Biochemistry. 2005 Feb 22;44(7):2545-54. doi: 10.1021/bi049247p. Biochemistry. 2005. PMID: 15709767

6

Perturbation of RET signaling in the embryonic kidney.

Ehrenfels CW, Carmillo PJ, Orozco O, Cate RL, Sanicola M. Ehrenfels CW, et al. Among authors: orozco o. Dev Genet. 1999;24(3-4):263-72. doi: 10.1002/(SICI)1520-6408(1999)24:3/4<263::AID-DVG9>3.0.CO;2-D. Dev Genet. 1999. PMID: 10322634

7

An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.

Kelly RK, Olson DL, Sun Y, Wen D, Wortham KA, Antognetti G, Cheung AE, Orozco OE, Yang L, Bailly V, Sanicola M. Kelly RK, et al. Among authors: orozco oe. Eur J Cancer. 2011 Jul;47(11):1736-46. doi: 10.1016/j.ejca.2011.02.023. Epub 2011 Mar 31. Eur J Cancer. 2011. PMID: 21458984

8

CRIPTO3, a presumed pseudogene, is expressed in cancer.

Sun C, Orozco O, Olson DL, Choi E, Garber E, Tizard R, Szak S, Sanicola M, Carulli JP. Sun C, et al. Among authors: orozco o. Biochem Biophys Res Commun. 2008 Dec 5;377(1):215-20. doi: 10.1016/j.bbrc.2008.09.113. Epub 2008 Oct 1. Biochem Biophys Res Commun. 2008. PMID: 18835250

9

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.

Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M. Adkins HB, et al. Among authors: orozco o. J Clin Invest. 2003 Aug;112(4):575-87. doi: 10.1172/JCI17788. J Clin Invest. 2003. PMID: 12925698 Free PMC article.

10

Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.

Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS. Wechselberger C, et al. Among authors: orozco o. Oncogene. 2005 Jun 9;24(25):4094-105. doi: 10.1038/sj.onc.1208417. Oncogene. 2005. PMID: 15897912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters